Clinical Trials Consumables

Clinical Trials Consumables Market Outlook

The global Clinical Trials Consumables market is projected to reach USD 12.4 billion by 2035, growing at a CAGR of 7.2% from 2025 to 2035. This growth is primarily driven by the increasing number of clinical trials being conducted worldwide, alongside the rising investment in research and development across pharmaceutical and biotechnology sectors. Additionally, the surge in demand for faster and more efficient clinical trial processes has prompted organizations to adopt advanced consumables that enhance laboratory efficiency and accuracy. The growing prevalence of chronic diseases necessitates extensive research, thus fueling the growth of the clinical trials consumables market. Furthermore, the expansion of personalized medicine and the increasing focus on patient-centric trials are also contributing significantly to market growth.

Growth Factor of the Market

Several factors are fueling the growth of the Clinical Trials Consumables market. First and foremost, the rise in the global incidence of chronic diseases, such as cancer and cardiovascular diseases, is prompting pharmaceutical companies to invest heavily in clinical trials. Governments are also actively supporting these endeavors through funding and regulatory frameworks, which encourages innovation and the development of new therapies. Secondly, the growing emphasis on clinical research and development within pharmaceuticals and biotechnology has sparked an increase in trial volumes, thereby boosting the demand for consumables. Another significant growth driver is the technological advancements in clinical trial methodologies, which require sophisticated consumables for efficient execution. Lastly, the expansion of clinical trials into emerging markets is creating new opportunities for consumables manufacturers, further propelling market growth.

Key Highlights of the Market

• The global Clinical Trials Consumables market is anticipated to reach USD 12.4 billion by 2035.
• North America holds the largest market share, driven by significant investments in R&D.
• The oncology segment accounts for the highest application demand due to rising cancer prevalence.
• Plastic-based consumables dominate the material type segment, owing to their versatility and cost-effectiveness.
• The market is witnessing an increase in online sales channels, reflecting a shift towards digitalization.

By Product Type

Bags & Pouches:

Bags and pouches are essential consumables in clinical trials, primarily used for the storage and transport of biological samples. These products are designed to maintain sample integrity, preventing contamination and degradation. Their flexible nature allows for easy handling, making them indispensable in clinical research settings. The increasing number of biobanks and the need for proper storage solutions in clinical trials are boosting the demand for bags and pouches. Moreover, advancements in material science have led to the development of specialized bags that offer superior barrier properties, enhancing sample preservation. As clinical trials expand globally, the importance of reliable and high-quality bags and pouches continues to grow.

Labels:

Labels play a critical role in clinical trials, ensuring accurate identification and tracking of samples and products throughout the research process. With the rising complexity of clinical trials, proper labeling has become more vital than ever to avoid mix-ups and misidentification. Labels are often designed to withstand various storage conditions, including extreme temperatures and humidity, ensuring that the information remains intact. Additionally, advancements in printing technology have enabled the production of high-quality, barcoded labels that enhance tracking efficiency. The increasing emphasis on data accuracy and integrity in clinical trials is significantly driving the demand for reliable labeling solutions.

Laboratory Consumables:

Laboratory consumables encompass a wide range of products used in clinical trials, including pipettes, test tubes, and petri dishes. These items are crucial for conducting experiments and ensuring reliable results. The growing focus on precision and accuracy in laboratory procedures is driving the demand for high-quality laboratory consumables. Furthermore, with the surge in personalized medicine and targeted therapies, laboratories require specialized consumables tailored to specific applications. The continuous evolution of research methodologies and technological advancements in laboratory equipment is also contributing to the growth of this segment.

Kits & Strips:

Kits and strips are essential for conducting various diagnostic tests in clinical trials, providing a convenient and standardized method for sample analysis. These consumables are designed to simplify testing processes, making them user-friendly for researchers. The increasing incidence of infectious diseases and the demand for rapid testing solutions are significantly driving the market for kits and strips. Additionally, advancements in technology have led to the development of more sophisticated kits that offer higher sensitivity and specificity, enhancing diagnostic accuracy. As the healthcare landscape evolves, the role of kits and strips in clinical trials continues to expand, making them a vital segment of the consumables market.

Tubes:

Tubes are fundamental consumables used in clinical trials for the collection, storage, and transportation of biological samples. Their design varies based on specific requirements, such as the type of sample being handled, whether it is blood, urine, or tissue. The increasing need for sample integrity and preservation is driving the demand for specialized tubes that minimize contamination and degradation. Innovations such as vacuum-sealed tubes and those with additives for sample stabilization are enhancing their functionality. As the number of clinical trials grows, the demand for high-quality tubes continues to rise, making them a critical component of the consumables market.

By Application

Oncology:

The oncology segment represents one of the largest applications within the clinical trials consumables market. With the increasing prevalence of cancer worldwide, there is a significant focus on developing effective therapies and treatment protocols. Clinical trials aimed at understanding cancer dynamics and testing new drugs necessitate a variety of consumables, including bags, tubes, and laboratory supplies. The stringent regulations surrounding oncology clinical trials also drive the demand for high-quality and reliable consumables that ensure accurate results. As the fight against cancer continues, the oncology segment is expected to maintain robust growth in the coming years.

Cardiovascular:

Cardiovascular clinical trials are critical for understanding heart diseases and developing new treatment options. The demand for consumables in this segment is driven by the increasing incidence of cardiovascular diseases globally. These trials require various consumables, including laboratory tools, tubes, and kits for diagnostic testing. The evolving landscape of cardiovascular research, with a focus on personalized medicine and innovative therapies, is creating a need for advanced consumables specifically designed for these applications. As awareness of heart health continues to grow, the cardiovascular segment is likely to expand significantly within the clinical trials consumables market.

Infectious Diseases:

The infectious diseases application has gained considerable attention, particularly in light of recent global health crises. Clinical trials focused on infectious disease treatments and vaccines require a broad range of consumables, including testing kits, laboratory supplies, and storage solutions. The urgency to develop effective treatments and preventive measures has led to increased demand for consumables that facilitate rapid and accurate testing. Furthermore, as research into emerging infectious diseases intensifies, the need for high-quality consumables tailored to these applications will continue to rise. The infectious diseases segment is poised for substantial growth in the clinical trials consumables market.

Neurology:

Clinical trials in neurology aim to address various neurological disorders, and they present unique challenges that often require specialized consumables. The complexity of neurological research underscores the importance of utilizing high-quality laboratory tools and supplies to ensure the integrity of test results. As the prevalence of neurological conditions like Alzheimer's and Parkinson's disease continues to rise, there is an increasing need for consumables that cater specifically to this field. Additionally, advancements in neurological research methodologies are contributing to the growth of the neurology segment within the clinical trials consumables market.

Others:

The "Others" category encompasses a variety of applications in the clinical trials consumables market that may not fall under specific headings. This could include trials related to endocrine disorders, autoimmune diseases, and more. Each of these areas has its unique requirements for consumables, driven by the need for innovation and research into new treatment therapies. As healthcare continues to evolve, the diversity of conditions being researched will drive the ongoing development and demand for consumables across various applications. This segment is essential for capturing the complete picture of clinical trials consumables, reflecting the breadth of ongoing research in the medical field.

By Distribution Channel

Direct Sales:

Direct sales play a vital role in the distribution of clinical trials consumables, allowing manufacturers to establish a direct relationship with their customers. This method enables companies to provide tailored solutions and support to research institutions and laboratories. By bypassing intermediaries, direct sales often lead to cost savings for both the supplier and the end-user. The direct interaction also facilitates better feedback and communication regarding product performance, helping manufacturers to continuously improve their offerings. As the market grows, the trend of direct sales is likely to expand, with more manufacturers choosing this approach to enhance customer satisfaction and streamline their operations.

Distributor Sales:

Distributor sales represent a significant channel for clinical trials consumables, leveraging established networks to reach a wider customer base. Distributors often have established relationships with laboratories and clinical research organizations, making them valuable assets for manufacturers looking to penetrate the market. This channel allows for efficient distribution of a diverse range of consumables, capitalizing on the distributors' knowledge of local markets and customer needs. As the demand for clinical trials consumables increases, the reliance on distributor sales is expected to grow, providing manufacturers with a robust platform for market expansion.

Online Sales:

Online sales channels have emerged as a vital distribution method in the clinical trials consumables market, providing convenience and accessibility for researchers. The digital transformation of the healthcare sector has facilitated the growth of e-commerce platforms that cater to clinical trials needs. Researchers can easily browse various products, compare prices, and place orders online, streamlining the procurement process. This shift towards online sales is also driven by the increasing trend of remote work and the need for flexible purchasing options. As technology continues to advance, online sales are anticipated to become an even more dominant force in the distribution of clinical trials consumables.

Retail Pharmacies:

Retail pharmacies, while not the primary distribution channel for clinical trials consumables, do play a role, particularly for certain types of consumables that may be needed on a smaller scale. These pharmacies often carry basic laboratory supplies and testing kits that can be utilized in various clinical research settings. The convenience of retail pharmacies allows researchers to quickly access consumables without extensive procurement processes. However, it is essential to note that specialized consumables required for clinical trials are primarily sourced through dedicated distributors or direct sales. Nevertheless, the availability of certain consumables in retail pharmacies contributes to the overall accessibility of products in the market.

Others:

Other distribution channels may include specialized suppliers, wholesalers, and medical equipment suppliers that cater to specific needs within the clinical trials consumables market. These channels enhance the accessibility and availability of a wide range of consumables necessary for research activities. The diversification of distribution channels allows manufacturers to reach various customer segments, ensuring that researchers have access to the products they require. As the clinical trials landscape continues to evolve, the role of these alternative distribution channels will become increasingly significant, providing additional avenues for growth and market penetration.

By Material Type

Plastic:

Plastic is the most widely used material in the clinical trials consumables market due to its versatility, cost-effectiveness, and durability. The lightweight nature of plastic makes it ideal for a variety of consumables, including tubes, bags, and pouches. Moreover, advancements in plastic manufacturing have led to the development of specialized materials that offer superior barrier properties, ensuring sample integrity and safety during transportation. With the increasing focus on reducing contamination risks in clinical research, plastic consumables are favored for their disposable nature and ease of use. As the demand for clinical trials continues to rise, plastic will remain a dominant material in this market segment.

Glass:

Glass is another essential material used in clinical trials consumables, particularly for items requiring a higher degree of chemical resistance and sample integrity. Glass tubes, vials, and containers are preferred in many laboratory settings for their inert properties, which prevent interaction with the samples. The recyclability of glass also supports sustainability efforts within the healthcare industry, making it an attractive option for many researchers. While glass is often more expensive than plastic, its superior characteristics justify the cost in critical applications. As research continues to emphasize sample purity and accuracy, glass consumables will maintain a significant presence in the market.

Metal:

Metal is less commonly used in clinical trials consumables but plays a crucial role in specific applications, particularly for equipment and tools that require durability and heat resistance. Stainless steel, for example, is often used in laboratory instruments and devices due to its strength and resistance to corrosion. The need for high-quality, long-lasting consumables in laboratories contributes to the demand for metal-based products. Additionally, advancements in metal manufacturing processes are enabling the production of specialized items tailored for clinical research applications. As the market evolves, the role of metal in clinical trials consumables will continue to grow, particularly in specialized research environments.

Paper:

Paper is utilized in various consumables within the clinical trials market, primarily in the form of labels, documentation, and packaging materials. The importance of accurate labeling in clinical research underscores the need for high-quality paper products that can withstand various storage conditions. The growing trend toward sustainable practices in the healthcare sector is also driving interest in paper-based consumables, as they are often more environmentally friendly than plastic alternatives. While paper may not be as durable as other materials, its role in ensuring proper organization and documentation in clinical trials is invaluable. As the market focuses on sustainability, paper products are likely to gain prominence in this segment.

Others:

The "Others" category in the material type segment encompasses various specialized materials that may be used in specific clinical trials consumables. These could include biodegradable materials, composite materials, or even innovative substances designed for unique applications in research. The emergence of new materials driven by technological advancements and sustainability efforts is creating opportunities for manufacturers to develop novel consumables that meet the evolving needs of clinical research. As the landscape of clinical trials continues to shift, the demand for specialized materials will likely increase, leading to further innovation and diversification in this market segment.

By Region

The North American region holds the largest share of the Clinical Trials Consumables market, accounting for approximately 40% of the total market value. The region's dominance is attributed to the robust infrastructure of pharmaceutical companies, extensive research facilities, and significant investment in clinical trials. Furthermore, the presence of leading market players and a well-established regulatory framework contribute to the growth of clinical trials in North America. The increasing incidence of chronic diseases and the demand for novel therapies are further propelling the market in this region. With a CAGR of 6.5% projected for North America during the forecast period, the region is expected to maintain its leadership in the clinical trials consumables market.

Europe follows closely as the second-largest market for clinical trials consumables, accounting for roughly 30% of the global share. The region is characterized by a strong focus on research and development within the pharmaceutical and biotechnology sectors, which drives the demand for consumables. The ongoing collaborations between academia and industry in Europe foster innovation and facilitate clinical trials, further boosting market growth. Additionally, the increasing prevalence of diseases such as cancer and cardiovascular disorders in Europe necessitates extensive clinical research, thereby enhancing the demand for consumables. As the market continues to evolve, the European region is poised for steady growth, supported by favorable regulatory environments and increasing investments in clinical research.

Opportunities

The Clinical Trials Consumables market presents numerous opportunities for growth, particularly as the global healthcare landscape evolves. One of the most significant opportunities lies in the expansion of clinical trials into emerging markets. Countries in Asia Pacific and Latin America are experiencing increased investment in healthcare infrastructure and research capabilities, creating a demand for high-quality consumables. By establishing partnerships with local organizations and tailoring products to meet regional needs, manufacturers can capitalize on these emerging markets and expand their customer base. Additionally, the growing trend of personalized medicine presents an opportunity for consumables manufacturers to develop specialized products that cater to specific patient populations, thus enhancing their market presence.

Another notable opportunity arises from the advancements in technology that are transforming clinical trials. The integration of digital tools, such as electronic data capture and remote monitoring, is changing the way clinical trials are conducted, leading to increased efficiency and accuracy. Consequently, there is a growing demand for consumables that complement these technological innovations. Manufacturers that focus on developing products aligned with digital transformation and automation in clinical research will be well-positioned to meet the evolving needs of researchers. By staying at the forefront of technological advancements and addressing the challenges faced by clinical trials, companies can uncover new opportunities for growth in the consumables market.

Threats

Despite the promising growth outlook for the Clinical Trials Consumables market, several threats could hinder progress. One of the primary challenges is the increasing regulatory scrutiny faced by manufacturers in the healthcare sector. Compliance with stringent regulations and quality standards can be time-consuming and costly, particularly for smaller companies with limited resources. Failure to meet these regulatory requirements can lead to product recalls, legal repercussions, and a damaged reputation. Additionally, the rapid pace of technological advancements in the industry means that companies must continuously innovate to stay competitive. Those unable to keep up with changing technologies may find themselves at a disadvantage, further exacerbating the challenges within this market.

Another significant threat stems from the rising competition in the clinical trials consumables market. As more companies enter the space, competition becomes fierce, leading to price wars and reduced profit margins. Established players face the challenge of maintaining their market share while competing against new entrants that may offer innovative solutions at lower prices. This competitive landscape requires companies to differentiate their products and demonstrate added value in order to retain customers. Moreover, economic fluctuations and changes in funding for clinical trials can impact the demand for consumables, leading to uncertainty in market growth. Addressing these threats will be crucial for companies seeking to navigate the complexities of the Clinical Trials Consumables market.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• BD (Becton, Dickinson and Company)
• Agilent Technologies
• Corning Incorporated
• VWR International
• SAB Biotherapeutics
• Pall Corporation
• Schott AG
• Eppendorf AG
• Roche Holding AG
• Siemens Healthineers
• Danaher Corporation
• Fisher Scientific
• Bio-Rad Laboratories

The competitive landscape of the Clinical Trials Consumables market is characterized by a mix of established players and emerging companies striving to capture market share. Leading firms such as Thermo Fisher Scientific and Merck KGaA dominate the market due to their extensive product portfolios, strong distribution networks, and commitment to innovation. These companies continuously invest in research and development to introduce new consumables that meet the evolving needs of clinical trials. By leveraging their expertise and resources, they can deliver high-quality products that adhere to stringent regulatory standards, ensuring their position as key players in the market.

Emerging companies are also making their mark in the Clinical Trials Consumables market, often focusing on niche segments or developing innovative solutions. These companies may capitalize on specific trends, such as sustainability or personalized medicine, to differentiate themselves from established competitors. By offering unique products or addressing unmet needs within the market, these emerging firms can carve out a space for themselves and challenge traditional players. Collaboration between established and emerging companies is also becoming more common, enabling knowledge transfer and access to new technologies that can enhance product offerings.

As competition intensifies, companies are increasingly prioritizing customer relationships and satisfaction. Understanding customer needs and preferences is essential for success in the Clinical Trials Consumables market. Leading players are investing in customer support and education initiatives to ensure that researchers can effectively utilize their products. By fostering strong relationships with clients and addressing their concerns, companies can enhance brand loyalty and repeat business. Additionally, as the market continues to evolve, businesses that prioritize innovation and adaptability will be better positioned to navigate the dynamic landscape and capitalize on emerging opportunities.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Schott AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Pall Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Holding AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fisher Scientific
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 VWR International
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Danaher Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 SAB Biotherapeutics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Agilent Technologies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Corning Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Siemens Healthineers
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Clinical Trials Consumables Market, By Application
    • 6.1.1 Oncology
    • 6.1.2 Cardiovascular
    • 6.1.3 Infectious Diseases
    • 6.1.4 Neurology
    • 6.1.5 Others
  • 6.2 Clinical Trials Consumables Market, By Product Type
    • 6.2.1 Bags & Pouches
    • 6.2.2 Labels
    • 6.2.3 Laboratory Consumables
    • 6.2.4 Kits & Strips
    • 6.2.5 Tubes
  • 6.3 Clinical Trials Consumables Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Glass
    • 6.3.3 Metal
    • 6.3.4 Paper
    • 6.3.5 Others
  • 6.4 Clinical Trials Consumables Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales
    • 6.4.3 Online Sales
    • 6.4.4 Retail Pharmacies
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Clinical Trials Consumables Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Clinical Trials Consumables market is categorized based on

By Product Type

• Bags & Pouches
• Labels
• Laboratory Consumables
• Kits & Strips
• Tubes

By Application

• Oncology
• Cardiovascular
• Infectious Diseases
• Neurology
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Sales
• Retail Pharmacies
• Others

By Material Type

• Plastic
• Glass
• Metal
• Paper
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• BD (Becton, Dickinson and Company)
• Agilent Technologies
• Corning Incorporated
• VWR International
• SAB Biotherapeutics
• Pall Corporation
• Schott AG
• Eppendorf AG
• Roche Holding AG
• Siemens Healthineers
• Danaher Corporation
• Fisher Scientific
• Bio-Rad Laboratories